| Authors: |
Coplan PM; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Adjunct, Epidemiology Department, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Chilcoat HD; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Butler SF; Inflexxion Inc., Newton, Massachusetts, USA., Sellers EM; DL Global Partners Inc, Toronto, Canada.; Pharmacology and Toxicology, Medicine and Psychiatry, University of Toronto, Toronto, Canada., Kadakia A; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA., Harikrishnan V; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA., Haddox JD; Department of Health Policy, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Public Health & Community Medicine, School of Medicine, Tufts University, Boston, Massachusetts, USA., Dart RC; Rocky Mountain Poison & Drug Center, Denver, Colorado, USA.; Surgery and Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA. |
